Today's Top Alzheimer's News

Researchers make urgent case for reforming biomedical research process in US, researchers use blood to reverse aging in mice, 60 Minutes highlights aging research, and Diane Keaton talks Alzheimer's (read more). 

Must reads

  • A May 5, 2014 Forbes article reported that "In the current issue of the Proceedings of the National Academy of Sciences (PNAS), four distinguished scientists make an urgent case for reforming how biomedical research is funded and carried out in the United States." According to the article, "Reforming the system to favor creativity and basic research that stands the best chance of yielding important clinical applications will hopefully help the US maintain what the authors refer to as the Golden Age of biomedicine."
  • A May 4, 2014 New York Times article reported that "Two teams of scientists published studies on Sunday showing that blood from young mice reverses aging in old mice, rejuvenating their muscles and brains." According to the article, "The experiment indicated that there were compounds in the blood of the young mice that could awaken old stem cells and rejuvenate aging tissue. Likewise, the blood of the old mice had compounds that dampened the resilience of the young mice…In a second study in Science, the team reported that parabiosis spurred the growth of blood vessels in the brain. The new blood supply led to the growth of neurons and gave older mice a sharper sense of smell."

Research and science 

  • A May 3, 2014 AP article via the Daily News (IN) reported that "The Alzheimer’s Drug Discovery Foundation (ADDF) raised more than $1.1 million in support of a clinical trial to test an existing drug for the treatment of Alzheimer’s disease." According to the article, "The $1.1 million was generated during the “Fund a Scientist” auction at its Eighth Annual Connoisseur’s Dinner on May 1, 2014, and awarded to Jeffrey Cummings, MD, director of the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, Nevada and Cleveland, Ohio. Dr. Cummings will investigate rasagiline, an FDA-approved treatment for Parkinson’s disease with the potential to be the first drug to slow the course of Alzheimer’s disease."

The arts 

  • A May 1, 2014 New York Times Sunday Book Review article highlighted actress Diane Keaton's connection to Alzheimer's. When asked what was the last truly great book she read, Keaton responded, "David Shenk’s “The Forgetting. Alzheimer’s: Portrait of an Epidemic.” My mother lived with Alzheimer’s for at least 15 years. This book is a terrifying, yet deeply moving exploration of an epidemic that stripped my mother of her life paragraph by paragraph, sentence by sentence, and finally word by word."  


^ Back to Top